Oculus Innovative Sciences Introduces MicrocynAH® Next-Generation Dermatology Products with Dimethicone for Animals
PETALUMA, Calif. — (September 24, 2015) — Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) (tradable warrants OCLSW), a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and advanced tissue care in both humans and animals, today announced the introduction of two new MicrocynAH® dermatology products for animals. MicrocynAH® Anti-Itch Spray Gel and [...]